Dalton to manufacture new med; DKSH takes Tiger Balm to Myanmar;

> The investment arm of Swedish CMDO Recipharm will hold a 25% stake in Pharmanest, a pain drug developer, after making a 8 million Swedish krona investment in it. Release

> Dalton Pharma Services today announced the signing of a drug development and manufacturing contract with Ramsey Lake Pharmaceutical Corp. Release

And Finally... Market expansion specialist DKSH has been hired by Haw Par Healthcare to handle sales of its Tiger Balm pain reliever in Myanmar. Release

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.